Infectious Dis.

Your Article Summary

See Latest Articles

Tigecycline for the treatment of patients with community-acquired pneumonia requiring hospitalization
Expert Review of Anti-infective Therapy, 10/09/09

Falagas ME et al. – Tigecycline was found to be noninferior compared with levofloxacin for the treatment of patients with bacterial CAP requiring hospitalization. Recently, the drug was approved for the treatment of these patients by the FDA, but owing to some concerns, its application in the EMEA has been withdrawn. In addition, in a recent study concerns were expressed about the efficacy of tigecycline in the lungs using the current dosage. More data are needed about the pharmacokinetics of tigecycline in the lungs and its efficacy in severe CAP.

Today in Antimicrobials...keeping you current

Receive free subspecialty "5-minute updates" via email

A Randomized, Double-Blind Study Examining the Comparative Efficacies and Safety of Inhaled Epinephrine and Nasal Decongestant in Hospitalized Infants With Acute Bronchiolitis
The Pediatric Infectious Disease Journal, 11/17/09

Acyclovir: a new use for an old drug
Current Opinion in Infectious Diseases, 10/28/09

H1N1 Vaccine Production, Availability Increasing Slowly
American Family Physician, 11/02/09

See All of Antimicrobials

Today in Pulm/Thoracic Infections...keeping you current

Receive free subspecialty "5-minute updates" via email

A Randomized, Double-Blind Study Examining the Comparative Efficacies and Safety of Inhaled Epinephrine and Nasal Decongestant in Hospitalized Infants With Acute Bronchiolitis
The Pediatric Infectious Disease Journal, 11/17/09

Management of H1N1 influenza virus respiratory syndrome
Minerva Anestesiologica, 11/11/09

H1N1 Vaccine Production, Availability Increasing Slowly
American Family Physician, 11/02/09

See All of Pulm/Thoracic Infections